
Regulatory Authority Website: https://www.tga.gov.au/
Database link: https://www.tga.gov.au/resources/artg

English.
1. Confirm whether the product is a medical device (Therapeutic Goods) in accordance with Section 41BDA of the Therapeutic Goods Act 1989
2.Appoint a Sponsor
3.Determine the risk classification of the medical device or IVD product
4.The Sponsor submits manufacturer evidence via the EBS portal
5.TGA approves the submitted manufacturer evidence
6.The Sponsor lodges the product registration application through the EBS portal
7.TGA conducts application review, with three potential outcomes:

A: The time of registration of medical device in TGA is related to many factors, product risk level、registration path、product technical documentation level、feedback speed of Sponsor and the workload of TGA officials and so on will jointly determine the registration cycle of the product.
① Registration of non-sterile/non-measured/non-reusable Class I products is expected to be approved within 1 month of submission of product documentation.
② Is/Im/Ir/IIa/IIb products can be approved within two months after submission, based on the approval of recognized country registration. If there is no approval of recognized country registration, it is necessary to initiate an application for review to TGA or a TGA accredited review body. In this way, it is necessary to consider whether the product has completed all tests as required, whether clinical tests have been completed or certificates have been obtained to assess the registration cycle.
③ In addition, even if the registration has been approved by a recognized country, the application may be fully reviewed by TGA, and if TGA issues a notice requesting a full review, the review cycle may vary from several months to one year depending on TGA's approval decision.
④ Class 3 medical devices and Class 4 in vitro diagnostic reagents have the longest registration application cycle, and TGA will conduct a comprehensive review of the product, and only through a comprehensive review of the product will be approved and obtained ARTG certificate.
A: If the medical device has a recognized country registration approval certificate or proof in the TGA registration, it does not need to issue a separate QMS certificate, TGA recognizes the ISO 13485 certificate and MDSAP certificate issued by a specific body, and if the TGA requires the manufacturer to supplement the QMS evidence during the audit process, the manufacturer also needs to meet the requirements of TGA.
A: Yes, TGA allows manufacturers to change Sponsors with the consent of the current Sponsor, and Wiselink AU can assist with the change.
A: Yes, but Wiselink does not recommend doing so. The manufacturer can select an independent third-party Sponsor to hold the ARTG certificate. The independent third-party Sponsor will not interfere with the manufacturer's sales business, and will actively cooperate with the manufacturer's goods import. Medical device products can be distributed to multiple dealers at the same time.
A: If the change content of the medical device product meets the scope allowed by TGA, Sponsor can submit the change application to TGA, and the product can be put into the Australian market after being approved by TGA.
